AstraZeneca Covid 19 Vaccine Shows 79% Efficacy in US Phase 3 Trial
AstraZeneca plc’s covid-19 vaccine, the company said that the jab showed an efficacy of 79 per cent in phase 3 trials in the US, Chile
Home
Page 3042
KreditBee Raises an Additional USD 70 Mn in Series C Funding Round
Bengaluru-based Fintech Lending Platform KreditBee’s holding entity, Finnov has raised an additional USD 70 million in a follow-on Series C round from TPG-backed NewQuest Capital
Dozens of Towns Isolated by Flooding in Australian State
Hundreds of people have been rescued from floodwaters that have isolated dozens of towns in Australia‘s most populous state New South Wales and forced thousands
Aurum Ventures Buys 15% in IT Consultancy Majesco
Real estate developer Aurum Ventures has acquired 14.78 per cent in IT consulting and software company Majesco through a subsidiary, Aurum Platz IT Private Limited,
Bank of Maharashtra Seeking Bids for Rupee Denominated Bonds
India is set to face its first test of demand for a riskier type of bank bond since the regulator introduced a cap on mutual
Coinbase Global Aims to go Public in April
Coinbase Global Inc., the biggest U.S. cryptocurrency exchange, is now aiming to go public in April after its plans for a direct listing this month
NHAI, Automakers Told to Tighten IT Security After Cyber Attack Threat
The Ministry of Road Transport and Highways on Sunday alerted NHAI, NHIDCL and its other wings besides automobile makers to augment their IT security systems
At 740 Million, Paytm Transactions Surpass Pre-Covid Level
Digital payments major Paytm said its payments gateway business processed close to 750 million transactions a month, surpassing pre-covid levels. The pandemic has accelerated the
First River Interlinking Project to be Signed Today
Prime Minister Narendra Modi on Monday will launch the ‘Jal Shakti Abhiyan: Catch the Rain’ campaign on World Water Day, which is celebrated on March
Ocugen Seeks to Sell 100 Mn Bharat Biotech’s Covaxin Doses in US in 2021
Ocugen Inc seeks to sell 100 million doses of India’s state-backed COVID-19 vaccine COVAXIN in the United States this year, the U.S. firm’s chief executive